Seiji Kaji
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Corrigendum to "Amyloid-β1-42 oligomers compromise oligodendrocyte precursor cells and disrupt blood-brain barrier integrity in vitro" [Brain Res. 1888 (2026) 150436].
Journal: Brain research
Published: July 20, 2026
A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.
Journal: Molecular therapy. Nucleic acids
Published: April 12, 2024
Corrigendum to "Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD" [Neurosci. Lett. 812 (2023) 137405].
Journal: Neuroscience letters
Published: March 05, 2024
A novel mouse model for investigating α-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy.
Journal: Molecular brain
Published: December 18, 2023
Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD.
Journal: Neuroscience letters
Published: May 02, 2023
CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging.
Journal: Nature neuroscience
Published: November 08, 2021
Perampanel Inhibits α-Synuclein Transmission in Parkinson's Disease Models.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 09, 2020
Adult-onset Repeat Rhabdomyolysis with a Very Long-chain Acyl-CoA Dehydrogenase Deficiency Due to Compound Heterozygous ACADVL Mutations.
Journal: Internal medicine (Tokyo, Japan)
Published: July 17, 2020
BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy.
Journal: Acta neuropathologica communications
Published: March 22, 2020
Last Updated: 09/26/2026